Tamer Refaat, Associate Director of Global Oncology at Cardinal Bernardin Cancer Canter – Loyola University Chicago, shared a post on LinkedIn:
“Is surgery always the right answer for T2 rectal cancer?
Or is it time to rethink the paradigm?
I’m honored to serve as the radiation oncology panelist for this multidisciplinary tumor board at ASCO GI, tackling one of the most debated and evolving topics in gastrointestinal oncology:
Management of T2 rectal cancer in 2026
With advances in imaging, staging, and radiation techniques, organ preservation strategies are increasingly challenging the traditional surgery-first approach. The role of radiation oncology—alone or integrated with systemic therapy—continues to expand, particularly for carefully selected patients seeking to avoid radical surgery without compromising oncologic outcomes.
This session brings together experts in gastroenterology, medical oncology, colorectal surgery, radiology, and radiation oncology to discuss real-world cases, emerging data, and patient-centered decision-making.
Multidisciplinary Tumor Board: Innovations in Management of T2 Rectal Cancer
Date: Saturday, January 10, 2026, 3:00 PM
Location: Moscone Center, San Francisco, ASCO Gastrointestinal Cancers Symposium
Looking forward to a thoughtful, evidence-based discussion with outstanding colleagues.
Join us—and bring your perspective on organ preservation vs surgery.
Excited to join such a wonderful group of experts!”
More posts featuring Tamer Refaat.